Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia.
Higashima
Masato
M
Department of Psychiatry and Neurobiology, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan. mtohma@med.kanazawa-u.ac.jp
Takeda
Tsutomu
T
Nagasawa
Tatsuya
T
Hirao
Naohisa
N
Oka
Takashi
T
Nakamura
Mitsuhiko
M
Kitamura
Maki
M
Koshino
Yoshifumi
Y
D000208:Acute Disease; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000008:administration & dosage / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000209:etiology*; D012559:Schizophrenia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*
D014150:Antipsychotic Agents; D008728:Methotrimeprazine; D006220:Haloperidol